Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06090916
NA

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

Sponsor: Jonsson Comprehensive Cancer Center

View on ClinicalTrials.gov

Summary

This clinical trial compares the effect of malnutrition screening and dietary intervention to standard nutrition care on patients with pancreatic cancer that cannot be removed by surgery (unresectable). Fewer than 20% of patients diagnosed with unresectable pancreatic cancer do not survive one year after diagnosis so treatment often focuses on improving quality of life. Many patients experience increasing pain, nausea, vomiting, loss of appetite, weight loss and weakness. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Screening for inadequate nutrition (malnutrition) and providing weekly nutritional support may be effective methods to improve nutritional status and improve overall quality of life for patients with unresectable pancreatic cancer.

Official title: Malnutrition Screening and Nutrition Optimization to Improve Outcomes in Patients With Unresectable Pancreatic Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2023-01-17

Completion Date

2027-03-31

Last Updated

2025-05-13

Healthy Volunteers

No

Interventions

OTHER

Best Practice

Receive standard nutrition care

OTHER

Dietary Intervention

Participate in weekly support sessions with diet prescription

OTHER

Medical Chart Review

Ancillary studies

OTHER

Medical Device Usage and Evaluation

Record dietary and physical activity using MyFitnessPal smartphone app

OTHER

Nutritional Assessment

Undergo malnutrition screening

OTHER

Questionnaire Administration

Ancillary studies

Locations (1)

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, United States